20 Jul 2021
“Europe’s drug regulator said on Tuesday it had started a real-time review of the COVID-19 vaccine developed by French drugmaker Sanofi and the UK’s GlaxoSmithKline, the fifth shot currently under such a review.
The decision to start the “rolling review” of the vaccine, Vidprevtyn, was based on preliminary results from lab studies and early stage clinical trials in adults, the European Medicines Agency (EMA) said.”
https://www.aljazeera.com/news/2021/7/20/eu-begins-real-time-review-of-sanofi-gsk-covid-19-vaccine
The agency’s rolling reviews are aimed at speeding up the approval process by allowing researchers to submit findings in real time before final trial data is available.
Sanofi said other rolling reviews of its vaccine were also about to start in the UK, Canada and Singapore, as well as with the World Health Organization.
Vidprevtyn uses the same technology as one of Sanofi’s seasonal influenza vaccines. It will be coupled with an adjuvant, a substance that acts as a booster to the shot, made by GSK.
The four vaccines with EMA authorisation in the EU are Pfizer-BioNTech, Moderna, AstraZeneca and Johnson & Johnson.
—
[ Mod: Once again you fail to distinguish between quotations and your own comments. A check reveals that all of these sentences (both above and below the URL) are quoted directly from the linked news article. ]